HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
NCT: NCT04177914 · ACTIVE_NOT_RECRUITING
Brief Summary
Hydrocephalus is a potentially debilitating neurological condition that primarily affects babies under a year of age and has traditionally been treated by inserting a shunt between the brain and the abdomen. A newer endoscopic procedure offers hope of shunt- free treatment that may reduce complications over a child's life, but it is not clear if the endoscopic procedure results in similar intellectual outcome as shunt. Therefore, the investigators propose a randomized trial to compare intellectual outcome and brain structural integrity between these two treatments, to help families make the best treatment decision for their baby.
Frequently Asked Questions
What is HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants?
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants is a clinical trial registered under NCT04177914. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT04177914?
The current status of NCT04177914 (HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants) is: ACTIVE_NOT_RECRUITING.
When did HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants start?
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants started on 2020-07-21.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.